John A. Lewicki

EVP & Chief Scientific Officer, OncoMed.

Companies

Mereo BioPharma Group plcChief Scientific Officer Jan 2, 2024 to now¹
OncoMedBoard member Apr 26, 2018 to Apr 23, 2019²
OncoMedChief executive officer Mar 19, 2018 to Apr 23, 2019³
OncoMedPresident Feb 6, 2018 to Apr 23, 2019⁴
OncoMedEVP & Chief Scientific Officer Jul 17, 2013 to Jan 8, 2018⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Mereo BioPharma Group plc MREO92,826 shares⁶$28.7K at $0.31Sep 16, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Sep 13, 2024Sold 10,937 shares at $4.22 of Mereo BioPharma Group plc⁶
Sep 12, 2024Sold 5,212 shares at $4.47 of Mereo BioPharma Group plc⁶
Sep 11, 2024Exercised options 46,000 shares of Mereo BioPharma Group plc⁷
Jun 26, 2024Sold 16,808 shares at $3.39 of Mereo BioPharma Group plc⁸
Jun 25, 2024Sold 7,416 shares at $3.69 of Mereo BioPharma Group plc⁸
Jun 21, 2024Exercised options 69,000 shares of Mereo BioPharma Group plc⁹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARMereo BioPharma Group plc, Chief Scientific Officer
2
SEC EDGAROncoMed, Board member
3
SEC EDGAROncoMed, Chief executive officer
4
SEC EDGAROncoMed, President
5
SEC EDGAROncoMed, EVP & Chief Scientific Officer
6
SEC EDGARMereo BioPharma Group plc shares after the filing of Sep 16, 2024
7
SEC EDGARForm 4 filed Sep 13, 2024
8
SEC EDGARForm 4 filed Jun 27, 2024
9
SEC EDGARForm 4 filed Jun 25, 2024